Archive for August, 2012

FDA recommends more consistent testing of metal-on-metal hip implants

The Food and Drug Administration has recommended that an expert panel consider more consistent testing of metal-on-metal hip implants. Staff from the FDA said the expert panel tasked with reviewing the faulty hip replacements should seriously consider imaging and ion testing as a way to prevent future device failures.

Read more about metal-on-metal hip implant testing…

Author’s new book warns of over-use of Zoloft

Author Karen Sharpe has written a new book on what she calls the pervasiveness of antidepressants such as Zoloft in American culture. Sharpe’s book, Coming Of Age On Zoloft: How Antidepressants Cheered Us Up, Let Us Down, And Changed Who We Are, includes research on the drug’s effects, as well as personal accounts from her nine-year use of the drug.

Read more about Zoloft in American culture…

Bard, doctor ordered to pay $5.5 M in transvaginal mesh lawsuit

A jury awarded a California woman $5.5 million in her transvaginal mesh lawsuit against the device’s manufacturer and the doctor who installed it. C.R. Bard was found 60% liable for the woman’s injuries after the device failed, while the doctor who performed the surgery was found 40% at fault.

Read more about transvaginal mesh lawsuits…

Already susceptible to bladder cancer, Actos increases risk in diabetes patients

A Canadian study has found that people who suffer from diabetes have a 40 percent higher risk of developing  bladder cancer. Research has solidified that Actos, a popular prescription drug used to treat type 2 diabetes, further increases this risk.

Read more about the connection between Actos and bladder cancer…

Bayer’s Yasmin settlements top $400 M

German drugmaker Bayer AG stated it has paid $402.6 million to settle Yasmin lawsuits alleging that the birth control pills caused blood clots. The company claims to have resolved nearly 1,900 birth control lawsuits for an average of $212,000 per case.

Read more about Bayer’s Yasmin settlements…

Actos may increase risk of macular edema

Type II diabetes drug Actos may substantially increase the risk of macular edema, according to new research published in the Archives of Internal Medicine. The risk of developing the eye condition was 230% greater up to 10 years after use among patients taking the diabetes medication.

Read more about Actos and macular edema…

New study finds that Propecia’s sexual side effects may be long-lasting

A new study published in the Journal of Sexual Medicine suggests the sexual side effects of Propecia may last from months to years for some men, even after they stop taking the drug. Researchers from George Washington University interviewed 54 men under age 40 who reported side effects for three months or more after taking Propecia.

Read more about the sexual side effects of Propecia…


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 434 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.